First malaria drug for newborns and young infants expected to be approved in Africa within weeks
Sanatate
CNN — The approval of the first malaria treatment for newborns and young infants could lead to imminent widespread use in Africa, drugmaker Novartis said Tuesday. The drug, known as Coartem Baby or Riamet Baby in some countries, has been approved by Swiss authorities for use in babies weighing between 2 kilograms (4 pounds, 6 ounces) and 5 kilograms (11 pounds) and is formulated to be easy for them to take, Novartis said. Coartem Baby already has approval in the West African nation of Ghana
astăzi